0 NASDAQ Companies - March 20, 2025Context Therapeutics Reports Full Year 2024 Operating and Financial ResultsCTIM-76 first patient dosed in January 2025 Cash and cash equivalents of $94.4 million as of December 31, 2024 Company […]Read More
0 NASDAQ Companies - March 20, 2025Context Therapeutics Reports Full Year 2024 Operating and Financial ResultsCTIM-76 first patient dosed in January 2025 Cash and cash equivalents of $94.4 million as of December 31, 2024 Company […]Read More
0 NASDAQ Companies - March 20, 2025EXL to Host Investor Strategy Update Event on May 6 in New YorkNEW YORK, March 20, 2025 (GLOBE NEWSWIRE) — ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, today […]Read More
0 NASDAQ Companies - March 20, 2025SEALSQ Announces FY 2024 Audited Financial Results and Strategic Growth Plan for 2025Geneva, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) — Schedules Conference Call and Webcast for Monday, March 24 at 10:00 am […]Read More
0 NASDAQ Companies - March 20, 2025SEALSQ Announces FY 2024 Audited Financial Results and Strategic Growth Plan for 2025Geneva, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) — Schedules Conference Call and Webcast for Monday, March 24 at 10:00 am […]Read More
0 NASDAQ Companies - March 20, 2025PLBY Group Announces Adjournment of Special Meeting of StockholdersLOS ANGELES, March 20, 2025 (GLOBE NEWSWIRE) — PLBY Group, Inc. (Nasdaq: PLBY) (the “Company” or “PLBY Group”), a leading […]Read More
0 NASDAQ Companies - March 20, 2025PLBY Group Announces Adjournment of Special Meeting of StockholdersLOS ANGELES, March 20, 2025 (GLOBE NEWSWIRE) — PLBY Group, Inc. (Nasdaq: PLBY) (the “Company” or “PLBY Group”), a leading […]Read More
0 NASDAQ Companies - March 20, 2025NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer ConferenceData evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a […]Read More
0 NASDAQ Companies - March 20, 2025NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer ConferenceData evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a […]Read More
0 NASDAQ Companies - March 20, 2025Palomar Holdings, Inc. Announces Agreement to Acquire Advanced AgProtectionLA JOLLA, Calif., March 20, 2025 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or the “Company”) today announced that […]Read More